Column GROUP Iii-a, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 124,988 shares at $17.79 ($2.2M) on 2020-08-27, disclosed to the SEC on 2020-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.79 | 36,359 | $647K | 29.0% |
| 2 | $17.79 | 36,359 | $647K | 29.0% |
| 3 | $17.89 | 26,135 | $468K | 21.0% |
| 4 | $17.89 | 26,135 | $468K | 21.0% |
| Total | $17.83 avg | 124,988 | $2.2M | 100% |
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |